MedPath

Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?

Not Applicable
Conditions
Infertility
Complications; Cesarean Section
Registration Number
NCT02371486
Lead Sponsor
Sheba Medical Center
Brief Summary

Cesarean scar defects (CSDs), i.e. deficient uterine scars following a cesarean section, involve discontinuity at the site of a previous Cesarean section scar. These anatomical defects have been reported to be associated with postmenstrual spotting, chronic pelvic pain and infertility. Few case series have suggested improved fertility (most probably by improving implantation of embryos) The aim of this study is to prospectively record embryonal implantation rate during IVF in patients with CSDs, and to evaluate the effect of hysteroscopic repair of CSDs on fetal implantation during IVF.

Detailed Description

150 patients undergoing IVF after cesarean section will be recruited. demographic, clinical and treatment data will be collected. ultrasound and hysteroscopic evaluation of the CSD will be performed. IVF treatment will be provided. In case of failure of IVF treatment, patients will be randomized to hysteroscopic repair of CSD versus second IVF treatment

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • Patients undergoing IVF after cesarean section
Exclusion Criteria
  • Patients who underwent CSD repair
  • Patients with low ovarian reserve
  • Patients with hydrosalpinges, endometriosis, adenomyosis, submucous fibroids or polyps

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Embryo implantation ratecompletion of two IVF cycles after randomization - approx. 2 months

Embryo implantation rate during IVF

Secondary Outcome Measures
NameTimeMethod
Fluid in Uteruscompletion of two IVF cycles after randomization - approx. 2 months

Detection of fluid in the uterine cavity during menotropin stimulation in IVF treatment

Correlation between the size and type of the defect and implantation rate during IVF treatmentcompletion of two IVF cycles after randomization - approx. 2 months

Correlation between the size and type of the defect and implantation rate during IVF treatment

Correlation between size and type of the defect fluid accumulationcompletion of two IVF cycles after randomization - approx. 2 months

Correlation between the size and type of the defect and the detection of fluid in the uterine cavity during menotropin stimulation in IVF treatment

Trial Locations

Locations (1)

The chaim sheba medical center,Tel Hashomer

🇮🇱

Ramat Gan, Israel

The chaim sheba medical center,Tel Hashomer
🇮🇱Ramat Gan, Israel
Roy Mashiach, MD
Contact
+97236130077
roy.mashiach@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.